NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-291-2012-0-CA-05 M971 Chimeric Antigen Receptors CA National Stage 2889055 Issued
NCI E-291-2012-0-IN-08 M971 Chimeric Antigen Receptors IN National Stage 2344/CHENP/2015 Issued
NCI E-291-2012-0-EP-07 M971 Chimeric Antigen Receptors EP National Stage 13773468.7 Issued
NCI E-291-2012-0-AU-03 M971 Chimeric Antigen Receptors AU National Stage 2013335180 Issued
NCI E-291-2012-0-JP-09 M971 Chimeric Antigen Receptors JP National Stage 2015-539602 Issued
NCI E-291-2012-0-PCT-02 M971 Chimeric Antigen Receptors PCT PCT PCT/US2013/060332 Expired
NCI E-190-2014-0-US-01 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS US 61/879,627 Abandoned
NHLBI E-259-2007-0-US-04 Nitrite And Nitrite-methemoglobin Therapy To Detoxify Stroma-free Hemoglobin Based Blood Substitutes US ORD 14/028,850 Abandoned
NCI E-765-2013-0-US-01 Multifunctional RNA Nanoparticles and Methods of Use US 61/878,758 Abandoned
NIAAA E-049-2016-0-EP-05 COMPOUND FOR USE IN PROTECTING SKIN EP National Stage 13762832.7 Issued
NIAAA E-049-2016-0-CA-04 COMPOUND FOR USE IN PROTECTING SKIN CA National Stage 2905545 Issued
NCI E-236-2012-0-CA-04 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY CA National Stage 2885761 Issued
NIAAA E-049-2016-0-AU-03 COMPOUND FOR USE IN PROTECTING SKIN AU National Stage 2013382361 Issued
NCI E-236-2012-0-CN-05 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY CN National Stage 201380060415.1 Issued
NCI E-236-2012-0-HK-09 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY HK EP 16100885.0 Issued
NIAAA E-049-2016-0-JP-07 COMPOUND FOR USE IN PROTECTING SKIN JP National Stage 2015-561958 Issued
NCI E-236-2012-0-EP-06 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY EP National Stage 13766859.6 Issued
NCI E-236-2012-0-AU-03 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY AU National Stage 2013324049 Issued
NHGRI E-060-2011-0-US-04 METHODS FOR TREATING LEUKEMIA AND DISORDERS MEDIATED BY CBFBETA AND RUNX1 PROTEINS US National Stage 14/005,534 9446048 Abandoned PDF
NIAAA E-049-2016-0-PCT-02 COMPOUND FOR USE IN PROTECTING SKIN PCT PCT PCT/EP2013/069189 Expired
NCI E-236-2012-0-PCT-02 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY PCT PCT PCT/US2013/059883 Expired
NHLBI E-126-2011-0-US-06 Acylation And Alkylation Of Amphipathic Peptides To Improve Their Biological And Therapeutic Properties US National Stage 14/114,386 Abandoned
NCI E-230-2012-0-CA-04 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 CA National Stage 2884743 Issued
NCI E-230-2012-0-CY-24 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 CY EP 13767200.2 Issued
NCI E-230-2012-0-BG-22 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 BG EP 13767200.2 Issued
NCI E-230-2012-0-CZ-25 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 CZ EP 13767200.2 Issued
NCI E-230-2012-0-HR-34 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 HR EP 13767200.2 Issued
NCI E-230-2012-0-AT-19 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 AT EP 13767200.2 Issued
NCI E-230-2012-0-AL-18 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 AL EP 13767200.2 Issued
NCI E-230-2012-0-BE-21 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 BE EP 13767200.2 Issued
NCI E-230-2012-0-RO-51 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 RO EP 13767200.2 Issued
NCI E-230-2012-0-PL-49 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 PL EP 13767200.2 Issued
NCI E-230-2012-0-SK-55 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 SK EP 13767200.2 Issued
NCI E-230-2012-0-RS-52 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 RS EP 13767200.2 Abandoned
NCI E-230-2012-0-NO-48 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 NO EP 13767200.2 Issued
NCI E-230-2012-0-MK-45 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 MK EP 13767200.2 Issued
NCI E-230-2012-0-NL-47 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 NL EP 13767200.2 Issued
NCI E-230-2012-0-SM-56 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 SM EP 13767200.2 Issued
NCI E-230-2012-0-PT-50 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 PT EP 13767200.2 Issued
NCI E-230-2012-0-MT-46 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 MT EP 13767200.2 Issued
NCI E-230-2012-0-SI-54 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 SI EP 13767200.2 Issued
NCI E-230-2012-0-LT-40 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 LT EP 13767200.2 Issued
NCI E-230-2012-0-LV-42 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 LV EP 13767200.2 Issued
NCI E-230-2012-0-LI-39 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 LI EP 13767200.2 Issued
NCI E-230-2012-0-IT-38 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 IT EP 13767200.2 Issued
NCI E-230-2012-0-LU-41 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 LU EP 13767200.2 Issued
NCI E-230-2012-0-IS-37 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 IS EP 13767200.2 Issued
NCI E-230-2012-0-HU-35 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 HU EP 13767200.2 Issued
NCI E-230-2012-0-GR-33 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 GR EP 13767200.2 Issued
NCI E-230-2012-0-IE-36 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 IE EP 13767200.2 Issued